Publication Name	World Journal of Gastroenterology
Manuscript ID	19254
Country	Spain

Received	2015-05-03 12:26
Peer-Review Started	2015-05-08 15:46
To Make the First Decision	2015-07-14 11:43
Return for Revision	2015-07-24 14:51
Revised	2015-08-05 00:58
Second Decision	2015-10-10 18:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-10-13 18:22
Articles in Press	2015-10-13 18:22
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-04 20:01
Publish the Manuscript Online	2016-01-20 16:55

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	New approaches in the treatment of hepatitis C
Manuscript Source	Invited Manuscript
All Author List	Rocío González-Grande, Miguel Jiménez-Pérez, Carolina González Arjona and José Mostazo Torres
Funding Agency and Grant Number
Corresponding Author	Miguel Jiménez-Pérez, MD, UGC de Aparato Digestivo, Unidad de Hepatología-Trasplante Hepático, Hospital Universitario Regional de Málaga, Avenida Carlos Haya, 29010 Malaga, Spain. mjimenezp@commalaga.com
Key Words	Hepatitis C; Treatment; Direct acting antiviral agents; Patients; Outcome
Core Tip	About 130-170 million people, is estimated to be infected with the hepatitis C virus. Chronic hepatitis C is one of the leading causes of liver-related death and in many countries it is the primary reason for having a liver transplant. Until a few years ago the only treatment strategy was based on the combination of pegylated interferon and ribavirin (RBV). Since 2011 the accelerated incorporation of direct acting antiviral agents has created a new scenario: increasing the rates of sustained viral response, shorter therapies, less toxicity and regimens free of interferon and/or RBV and can even modify the natural history of the disease.
Publish Date	2016-01-20 16:55
Citation	González-Grande R, Jiménez-Pérez M, González Arjona C, Mostazo Torres J. New approaches in the treatment of hepatitis C. World J Gastroenterol 2016; 22(4): 1421-1432
URL	http://www.wjgnet.com/1007-9327/full/v22/i4/1421.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i4.1421

Full Article (PDF)	WJG-22-1421.pdf
Full Article (Word)	WJG-22-1421.doc
Manuscript File	19254-Review.docx
Answering Reviewers	19254-Answering reviewers.pdf
Audio Core Tip	19254-Audio core tip.aiff
Conflict-of-Interest Disclosure Form	19254-Conflict-of-interest statement.pdf
Copyright License Agreement	19254-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	19254-Language certificate.pdf
Peer-review Report	19254-Peer-review(s).pdf
Scientific Misconduct Check	19254-Scientific misconduct check.pdf
Scientific Editor Work List	19254-Scientific editor work list.pdf